JOURNAL OF AFFECTIVE DISORDERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2026-03-06 ms6000001676569949 来自湖南省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：机器学习;健康;心理
经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕

69 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2025-12-31 dingneurology 来自安徽省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振
经验分享：Jul 16, 2025 submit
2025-08-08 18:52 Your submitted manuscript is currently under review
2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise
2025-10-12 20:51 submit R1
2025-12-12 13:50 Minor Revise
2025-12-16 13:45 submit R2
2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.  

166 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2025-05-21 ms9000001908456775 来自香港

3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救

133 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2021-08-18 1245fbebm84暂无昵称

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：抑郁
经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。

242 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2025-03-19 ms4000000558039719 来自广东省

呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜

136 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2023-01-30 柯斯质粒来自重庆

各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧

205 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2023-08-14 ms4000001493311070 来自新疆

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：焦虑抑郁
经验分享：with editor 已经10天了，还没有变化

189 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2024-06-20 ms8000000016852982 来自陕西省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：抑郁
经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了

229 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2024-08-23 ms5000001405944333 来自江西省

偏重的研究方向：精神
经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。

228 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2302687, encodeId=3188230268e22, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：机器学习;健康;心理 经验分享：目前在DIP阶段，不知道这个阶段是不是正常流程，有点害怕, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dec55688274, createdName=ms6000001676569949, createdTime=Fri Mar 06 22:21:15 CST 2026, time=2026-03-06, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2295336, encodeId=c4c1229533663, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：衰老;阿尔茨海默病;多模态核磁共振 经验分享：Jul 16, 2025 submit 2025-08-08 18:52 Your submitted manuscript is currently under review 2025-09-11 01:33 Decision on submission to Journal of Affective Disorders Major Revise 2025-10-12 20:51 submit R1 2025-12-12 13:50 Minor Revise 2025-12-16 13:45 submit R2 2025-12-30 21:55 I am pleased to inform you that your manuscript has been accepted for publication.   , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=dingneurology, createdTime=Wed Dec 31 08:32:59 CST 2025, time=2025-12-31, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2265972, encodeId=3ee122659e2bc, content=3.10投稿，然后说格式问题，修改后3.12重新投稿，WE，3.30时间变化了一次，状态依然WE，直到现在已经5.21了，已经两个多月了，上周写了催稿信，依然没有收到任何消息，这种情况下应该怎么办呢，求救 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa958586989, createdName=ms9000001908456775, createdTime=Wed May 21 10:29:11 CST 2025, time=2025-05-21, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1009157, encodeId=9f34100915e2a, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：抑郁 经验分享：一共投过两篇，第一篇major revision后拒稿，前后两个月左右时间。另一篇7月1日投，7月25返回审稿意见，minor revision 后，8月6日接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b8c2482497, createdName=1245fbebm84暂无昵称, createdTime=Wed Aug 18 15:56:02 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2256812, encodeId=5b262256812e3, content=呜呜呜，在返修期间申请删减作者，直接被拒了，呜呜呜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bafc8379845, createdName=ms4000000558039719, createdTime=Wed Mar 19 22:13:37 CST 2025, time=2025-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2112142, encodeId=ae6721121422b, content=各位大哥，我想请问一下投稿完了以后需要所有的作者通过邮件确认吗，好像给每一个作者都发了一封邮件，但是稿件状态显示是Submitted to Journal，每个作者都去注册账号也太麻烦了吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220104/6b1f3bcedf774d428d43f5a41ed9f335/3e9e5f99a0a54e3d994b914f9be6b7fd.jpg, createdBy=0b852474171, createdName=柯斯质粒, createdTime=Mon Jan 30 16:34:09 CST 2023, time=2023-01-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2152773, encodeId=b6c82152e7379, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：焦虑抑郁 经验分享：with editor 已经10天了，还没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=189, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=18968674845, createdName=ms4000001493311070, createdTime=Mon Aug 14 23:44:59 CST 2023, time=2023-08-14, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2210740, encodeId=df4d2210e4026, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：抑郁 经验分享：2023 11.月初投 2023 12 19送审 2024.1.21左右小修，2024.1.24 accept 1.25 好像就online 后面再投几个也不给送审了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ff28281703, createdName=ms8000000016852982, createdTime=Thu Jun 20 03:29:15 CST 2024, time=2024-06-20, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2222036, encodeId=b58a222203608, content=偏重的研究方向：精神 经验分享：投的有关ADHD的孟德尔随机化，两天后拒稿，说是不符合期刊的scope。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66448720153, createdName=ms5000001405944333, createdTime=Fri Aug 23 12:21:30 CST 2024, time=2024-08-23, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2221049, encodeId=bdb92221049c2, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：PTSD;多模态脑影像 经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。 Received at Editorial Office 5 Dec 2023 Article revised 16 Aug 2024 Article accepted for publication 17 Aug 2024 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202604/9f6b5e2f6c0541e9ac35f2231024e928-5gQ3Z26I1ZE2.png, createdBy=d1304659886, createdName=306523804, createdTime=Sun Aug 18 09:53:04 CST 2024, time=2024-08-18, status=1, ipAttribution=安徽省)]

2024-08-18 306523804 来自安徽省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：PTSD;多模态脑影像
经验分享：邀请审稿人时间比较漫长，审稿速度还算快，审稿意见也很专业，学到了很多，感谢。
Received at Editorial Office
5 Dec 2023
Article revised
16 Aug 2024
Article accepted for publication
17 Aug 2024

212 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务